Business Description
Evgen Pharma PLC
ISIN : GB00BSVYN304
Description
Evgen Pharma PLC is a UK-based clinical-stage drug development company. The company is focused on the development of sulforaphane-based compounds. Its core technology is Sulforadex, which synthesis and stabilizes the naturally occurring compound sulforaphane. Geographically, the company operates only in the United Kingdom. It is engaged in the treatment of breast cancer and Subarachnoid Haemorrhage.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.91 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -5.04 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 9.1 | |||||
| 3-Year EPS without NRI Growth Rate | 10.6 | |||||
| 3-Year FCF Growth Rate | 9.1 | |||||
| 3-Year Book Growth Rate | -15.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 69.22 | |||||
| 9-Day RSI | 43.36 | |||||
| 14-Day RSI | 36.39 | |||||
| 6-1 Month Momentum % | -51.28 | |||||
| 12-1 Month Momentum % | -75.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.39 | |||||
| Quick Ratio | 10.39 | |||||
| Cash Ratio | 8.98 | |||||
| Days Sales Outstanding | 166.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -26.9 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -513.96 | |||||
| Net Margin % | -400.12 | |||||
| FCF Margin % | -420.17 | |||||
| ROE % | -61.29 | |||||
| ROA % | -55.59 | |||||
| ROIC % | -1025.04 | |||||
| ROC (Joel Greenblatt) % | -2006.37 | |||||
| ROCE % | -78.72 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.58 | |||||
| PB Ratio | 0.55 | |||||
| Price-to-Tangible-Book | 0.8 | |||||
| EV-to-EBIT | 0.07 | |||||
| EV-to-Forward-EBIT | -0.23 | |||||
| EV-to-EBITDA | 0.07 | |||||
| EV-to-Forward-EBITDA | -0.23 | |||||
| EV-to-Revenue | -0.37 | |||||
| EV-to-Forward-Revenue | 2.36 | |||||
| EV-to-FCF | 0.12 | |||||
| Price-to-Net-Current-Asset-Value | 0.8 | |||||
| Price-to-Net-Cash | 0.8 | |||||
| Earnings Yield (Greenblatt) % | 1346.28 | |||||
| FCF Yield % | -102.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Evgen Pharma PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 0.838 | ||
| EPS (TTM) (£) | -0.012 | ||
| Beta | 2.02 | ||
| Volatility % | 44.3 | ||
| 14-Day RSI | 36.39 | ||
| 14-Day ATR (£) | 0.000665 | ||
| 20-Day SMA (£) | 0.008025 | ||
| 12-1 Month Momentum % | -75.32 | ||
| 52-Week Range (£) | 0.007 - 0.0405 | ||
| Shares Outstanding (Mil) | 427.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Evgen Pharma PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Evgen Pharma PLC Stock Events
| Event | Date | Price(£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Evgen Pharma PLC Frequently Asked Questions
What is Evgen Pharma PLC(LSE:EVG)'s stock price today?
The current price of LSE:EVG is £0.01. The 52 week high of LSE:EVG is £0.04 and 52 week low is £0.01.
When is next earnings date of Evgen Pharma PLC(LSE:EVG)?
The next earnings date of Evgen Pharma PLC(LSE:EVG) is 2024-06-07 Est..
Does Evgen Pharma PLC(LSE:EVG) pay dividends? If so, how much?
Evgen Pharma PLC(LSE:EVG) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers